Shareholders have voted to approve the business combination of Sonnet BioTherapeutics & Hyperliquid Strategies Inc.
Bob Diamond mode.
Hyperliquid.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Shareholders have voted to approve the business combination of Sonnet BioTherapeutics & Hyperliquid Strategies Inc.
Bob Diamond mode.
Hyperliquid.